- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/50 - Cyclic peptides containing at least one abnormal peptide link
Patent holdings for IPC class C07K 7/50
Total number of patents in this class: 332
10-year publication summary
|
18
|
32
|
24
|
16
|
19
|
35
|
13
|
24
|
21
|
14
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Protagonist Therapeutics, Inc. | 154 |
16 |
| Ohio State Innovation Foundation | 2383 |
10 |
| Centre National de La Recherche Scientifique | 11042 |
7 |
| Chugai Seiyaku Kabushiki Kaisha | 1421 |
7 |
| Peptidream Inc. | 106 |
7 |
| The University of Tokyo | 4372 |
7 |
| Napp Pharmaceutical Group Limited | 23 |
6 |
| Bicyclerd Limited | 150 |
6 |
| Bristol-myers Squibb Company | 4747 |
5 |
| University of Rochester | 1335 |
5 |
| Fog Pharmaceuticals, Inc. | 9 |
5 |
| Parabilis Medicines, Inc. | 28 |
5 |
| Merck Sharp & Dohme Corp. | 2183 |
4 |
| Aileron Therapeutics, Inc. | 78 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2666 |
4 |
| Merck Sharp & Dohme LLC | 3737 |
4 |
| Bayer Cropscience LP | 270 |
3 |
| Apellis Pharmaceuticals, Inc. | 136 |
3 |
| DSM Sinochem Pharmaceuticals Netherlands B.V. | 60 |
3 |
| Ferring B.V. | 714 |
3 |
| Other owners | 218 |